|
|
|
|
|
|
by cjs_ac
34 days ago
|
|
|
> All the spirallers that AFP spoke to said the positive feedback from the chatbot felt similar to dopamine hits from some kind of drug. > Which is why Lucy Osler, a philosophy lecturer at the University of Exeter, warned that AI companies could be tempted to ramp up the sycophancy of their bots. > "They are in quite a deep financial hole, and are desperately looking to make sure that their products become viable -- and user engagement is going to be the thing that drives their decisions," she told AFP. Sounds like the big social media companies. |
|
|
I agree. Looking at the history of tobacco companies, oxycontin and Meta, I will not be surprised if the AI companies will follow the money.